Physician profile
Dirk M Smith
NPI 1346242617
$7,325.37
in general payments reported to CMS, 2019-2025
42 companies · $1,547 in 2025
The $1,547 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $504 · 2021: $1,469 · 2022: $932 · 2023: $845 · 2024: $952 · 2025: $1,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,279 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,279.35 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,146.03 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $845.01 | 2019-2025 | |
| Amgen INC. | $743.51 | 2019-2025 | Evenity, Otezla, Prolia |
| Abbvie INC. | $534.30 | 2019-2024 | Ubrelvy, Qulipta, Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $502.52 | 2019-2025 | Jardiance, Ofev |
| Lilly USA, LLC | $492.90 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $480.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Eisai INC. | $451.11 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $202.78 | 2021 | |
| Exact Sciences Corporation | $193.50 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $146.42 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $138.73 | 2019-2022 | |
| Astellas Pharma US INC | $135.27 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $122.51 | 2022 | |
| Allergan, INC. | $108.16 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dirk Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.